Federated Hermes, Inc. Kodiak Sciences Inc. Transaction History

Federated Hermes, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.8 - $7.49 $2,512 - $10,456	1,396 New	1,396 $2,000
Q1 2023 May 08, 2023	SELL	$4.81 - $8.88 $1.27 Million - $2.34 Million	-263,836 Reduced 28.42%	664,430 $4.12 Million
Q4 2022 Feb 13, 2023	BUY	$6.52 - $8.05 $3.32 Million - $4.1 Million	508,704 Added 121.25%	928,266 $6.65 Million
Q3 2022 Nov 14, 2022	BUY	$7.57 - $12.5 $1.86 Million - $3.08 Million	246,353 Added 142.23%	419,562 $3.25 Million
Q2 2022 Aug 15, 2022	BUY	$5.04 - $9.48 $872,973 - $1.64 Million	173,209 New	173,209 $1.32 Million
Q1 2021 May 13, 2021	SELL	$110.45 - $164.47 $9.13 Million - $13.6 Million	-82,667 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$60.78 - $154.03 $5.02 Million - $12.7 Million	82,632 Added 236091.44%	82,667 $12.1 Million
Q3 2020 Nov 12, 2020	SELL	$45.05 - $59.27 $689,129 - $906,653	-15,297 Reduced 99.77%	35 $2,000
Q2 2020 Aug 13, 2020	BUY	$42.74 - $66.25 $333,970 - $517,677	7,814 Added 103.94%	15,332 $830,000
Q1 2020 May 13, 2020	SELL	$38.18 - $73.95 $419,101 - $811,749	-10,977 Reduced 59.35%	7,518 $359,000
Q4 2019 Feb 14, 2020	BUY	$13.9 - $76.65 $182,381 - $1.01 Million	13,121 Added 244.16%	18,495 $1.33 Million
Q3 2019 Nov 14, 2019	BUY	$10.24 - $17.57 $55,029 - $94,421	5,374 New	5,374 $77,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.